SCHEMBL22073758

SCHEMBL22073758

CO[C@H]1[C@H](OC(C)=O)[C@@H](COCc2ccccc2)OC(O)[C@@H]1OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GJB2 P29033 1/20 0.46
NT5E P21589 1/20 0.46
TACR2 P21452 3/20 0.45
TNF P01375 1/20 0.45
TSHR P16473 1/20 0.45
SSTR1 P30872 1/20 0.43
SSTR2 P30874 1/20 0.43
SSTR4 P31391 1/20 0.43
SSTR3 P32745 1/20 0.43
SSTR5 P35346 1/20 0.43
LMNA P02545 2/20 0.42
PTPN1 P18031 5/20 0.42
CDC25B P30305 3/20 0.42
PTPN2 P17706 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP2D6 P10635 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1775948 0.94 NT5E (0.48) NT5ETACR2TNFTSHRSSTR1
SCHEMBL1775945 0.94 NT5E (0.48) NT5ETACR2TNFTSHRSSTR1
SCHEMBL22073055 0.94 TSHR (0.50) NT5ETACR2TSHRLMNAPTPN1
SCHEMBL8225871 0.90 NT5E (0.51) NT5ETACR2TSHRSSTR1SSTR2
SCHEMBL2482599 0.90 NT5E (0.51) NT5ETACR2TSHRSSTR1SSTR2
SCHEMBL18241576 0.90 NT5E (0.51) NT5ETACR2TSHRSSTR1SSTR2
SCHEMBL18744567 0.90 NT5E (0.51) NT5ETACR2TSHRSSTR1SSTR2
SCHEMBL4181388 0.90 NT5E (0.51) NT5ETACR2TSHRSSTR1SSTR2
SCHEMBL19731824 0.90 NT5E (0.51) NT5ETACR2TSHRSSTR1SSTR2
SCHEMBL20295300 0.90 NT5E (0.51) NT5ETACR2TSHRSSTR1SSTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020114418-A1 ANTICOAGULANT PENTASACCHARIDE COMPOUND, COMPOSITION, AND PREPARATION METHOD AND MEDICAL USE THEREOF 南京正大天晴制药有限公司 2020-06-11 WO disclosed